Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCipla

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Here are top 10 stocks to focus on January 6

      Here are top 10 stocks to focus on January 6 – Cairn India, ONGC, HPCL, Andhra Bank, Idea Cellular, Bharti Airtel, Sesa Sterlite, Cipla, IRB Infra and Syndicate Bank.

    • Prefer Glenmark, Lupin: Dilip Bhat

      Dilip Bhat of Prabhudas Lilladher is of the view that one may prefer Lupin, Cipla or a Glenmark from pharma space.

    • Prefer pharma space, says Dilip Bhat

      According to Dilip Bhat of Prabhudas Lilladher, one may bet on pharmaceutical space.

    • Prefer Cipla, Wockhardt: Sudarshan Sukhani

      According to Sudarshan Sukhani of s2analytics.com, one may prefer Cipla and Wockhardt.

    • Prefer Asian Paints for long term: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Asian Paints for long term.

    • Prefer banking, pharma stocks: Rahul Mohindar

      Rahul Mohindar of viratechindia.com is of the view that one may prefer banking and pharma stocks.

    • Hold Cipla, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends holding Cipla with a long term view.

    • Go long in Cipla, says Ashish Chaturmohta

      Ashish Chaturmohta of Fortune Equity Broker recommends going long in Cipla as the stock may test Rs 680-690 in next five-seven trading sessions.

    • Colgate Palmolive looks expensive: Sanjeev Prasad

      According to Sanjeev Prasad, Senior Executive Director and Co-Head at Kotak Institutional Equities, Colgate Palmolive is looking expensive.

    • Buy Cipla for long term, says Parag Thakkar

      Parag Thakkar of HDFC Securities recommends going long in Cipla.

    • 3 reasons why BofA-Merrill is still hot on Cipla

      The multinational pharmaceutical company with current market capitalisation of nearly Rs 51,000 crore has a portfolio that includes 2000 products in 65 therapeutic categories with one quality standard globally.

    • Super Six: Top chart picks for November 21

      Vishal Kshatriya of Edelweiss recommends buying Hexaware Technologies for a target price of Rs 235-240 and Cipla with a target of Rs 640.

    • Buy Cipla; sell Apollo Tyres, HDIL: Mithil Pradhan

      Mithil Pradhan of Violet Arc Global Managers recommends going long in Cipla with a target of Rs 650-670.

    • Bullish on pharma; buy Lupin, Dr Reddys, Ipca: JM Financial

      For the largecap pharma companies the game has become completely US-cued. So, US will be the driver for Dr Reddys and Lupin, says Anmol Ganjoo.

    • Hold Cipla, says Kunal Saraogi

      According to Kunal Saraogi, CEO at Equityrush, one may hold Cipla.

    • Stay invested in Cipla, says Phani Sekhar

      Phani Sekhar, Fund Manager-PMS at Angel Broking is of the view that one can stay invested in Cipla.

    • Buy Cipla, Reliance Ind may move up by 7%: Murlidharan

      Manoj Murlidharan of Religare Securities recommends buying Cipla and feels that Reliance Industries may move up by 7 percent.

    • Buy Cipla, Infosys: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Cipla and Infosys.

    • Buy Apollo Tyres, Thomas Cook, Cipla, Escorts: Mukadam

      Shahina Mukadam of Varun Capital recommends buying Escorts with a target of Rs 178 and Cipla with a target of Rs 660.

    • Bull's Eye: Buy Apollo Tyres, Voltas, IRB Infra, Oil India

      AK Prabharkar, Independent Advisor advises buying Oil India for a target price of Rs 630 and Max India for a target price of Rs 343.

    • Super Six trading ideas for the day

      Manav Chopra of Nirmal Bang advises buying Bank of Baroda with a target of Rs 960 and Voltas with a target of Rs 265.

    • Cipla may touch Rs 685-690, says Yogesh Mehta

      Yogesh Mehta of Motilal Oswal Securities is of the view that Cipla may touch Rs 685-690.

    • Buy Cipla, BPCL, Tata Motors: Rahul Mohindar

      Rahul Mohindar of viratechindia.com advises buying Cipla with target of Rs 670.

    • Cipla may test Rs 640, says Kunal Bothra

      Kunal Bothra - Head Analyst, Technical at LKP Securities is of the view that Cipla may test Rs 640.

    • Buy Cipla, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Cipla.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347